Open AccessEffect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis
Author(s) -
Roy Fleischmann,
J. Wollenhaupt,
Stanley Cohen,
Lisy Wang,
Heng Fan,
Vara Bandi,
John S. Andrews,
Liza Takiya,
Eustratios Bananis,
Michael E. Weinblatt
Publication year - 2018
Publication title -
rheumatology and therapy
Language(s) - English
Resource type - Journals
eISSN - 2198-6584
pISSN - 2198-6576
DOI - 10.1007/s40744-018-0093-7
Subject(s) - tofacitinib , discontinuation , medicine , rheumatoid arthritis , concomitant , methotrexate , janus kinase inhibitor , gastroenterology , surgery
Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). We evaluated the effect of concomitant methotrexate (MTX) or glucocorticoid (GC) use on tofacitinib clinical efficacy.